Raymond Skwierczynski serves as Executive at CoLucid Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Raymond Skwierczynski has executed 10 insider transactions totaling $34.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 1, 2017 involved transacting 3,615 shares valued at $168.1K.
Raymond Skwierczynski currently holds 47 shares of CoLucid Pharmaceuticals, Inc. (CLCD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Raymond Skwierczynski has been a net seller of CLCD stock. They have purchased $0 and sold $34.4K worth of shares.
Raymond Skwierczynski's most recent insider trade was on Mar 1, 2017, when they sold 3,615 shares at $46.50 per share.
Get notified when new Form 4 filings are submitted
| $10.86 |
| Discretionary |
| Aug 19, 2016 | CLCD | $4.3K | Sale | 508 | $8.41 | Discretionary |
| Aug 10, 2016 | CLCD | $4.2K | Sale | 508 | $8.30 | Discretionary |
| Jul 29, 2016 | CLCD | $4.6K | Sale | 508 | $9.09 | Discretionary |
| Jul 20, 2016 | CLCD | $4.6K | Sale | 508 | $8.97 | Discretionary |
| Jul 11, 2016 | CLCD | $4.6K | Sale | 508 | $9.10 | Discretionary |
| Jun 30, 2016 | CLCD | $3.6K | Sale | 516 | $7.01 | Discretionary |
| Jun 20, 2016 | CLCD | $3.5K | Sale | 500 | $7.00 | Discretionary |
| Jun 10, 2016 | CLCD | $3.4K | Sale | 508 | $6.60 | Discretionary |